JANX vs. USLM
Compare and contrast key facts about Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM).
Performance
JANX vs. USLM - Performance Comparison
Loading graphics...
JANX vs. USLM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JANX Janux Therapeutics, Inc. | 5.14% | -74.22% | 398.97% | -18.53% | -33.25% | -21.55% |
USLM United States Lime & Minerals, Inc. | 13.48% | -9.59% | 188.91% | 64.34% | 9.84% | -8.79% |
Fundamentals
JANX:
$899.14M
USLM:
$3.90B
JANX:
-$2.54
USLM:
$4.67
JANX:
50.29
USLM:
10.47
JANX:
0.94
USLM:
6.19
JANX:
$17.88M
USLM:
$372.73M
JANX:
$8.44M
USLM:
$182.31M
JANX:
-$144.65M
USLM:
$186.33M
Returns By Period
In the year-to-date period, JANX achieves a 5.14% return, which is significantly lower than USLM's 13.48% return.
JANX
- 1D
- 4.39%
- 1M
- 8.12%
- YTD
- 5.14%
- 6M
- -38.78%
- 1Y
- -45.88%
- 3Y*
- 6.24%
- 5Y*
- —
- 10Y*
- —
USLM
- 1D
- 3.98%
- 1M
- 8.23%
- YTD
- 13.48%
- 6M
- 3.69%
- 1Y
- 49.16%
- 3Y*
- 64.91%
- 5Y*
- 38.39%
- 10Y*
- 29.24%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JANX vs. USLM — Risk / Return Rank
JANX
USLM
JANX vs. USLM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JANX | USLM | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.58 | 1.28 | -1.86 |
Sortino ratioReturn per unit of downside risk | -0.33 | 1.87 | -2.20 |
Omega ratioGain probability vs. loss probability | 0.94 | 1.23 | -0.29 |
Calmar ratioReturn relative to maximum drawdown | -0.71 | 2.40 | -3.12 |
Martin ratioReturn relative to average drawdown | -1.19 | 6.50 | -7.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JANX | USLM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.58 | 1.28 | -1.86 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.10 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.82 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | 0.26 | -0.35 |
Correlation
The correlation between JANX and USLM is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
JANX vs. USLM - Dividend Comparison
JANX has not paid dividends to shareholders, while USLM's dividend yield for the trailing twelve months is around 0.18%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JANX Janux Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USLM United States Lime & Minerals, Inc. | 0.18% | 0.20% | 0.15% | 0.35% | 0.57% | 0.50% | 0.56% | 6.52% | 0.76% | 0.70% | 0.66% | 0.91% |
Drawdowns
JANX vs. USLM - Drawdown Comparison
The maximum JANX drawdown since its inception was -83.14%, which is greater than USLM's maximum drawdown of -77.09%. Use the drawdown chart below to compare losses from any high point for JANX and USLM.
Loading graphics...
Drawdown Indicators
| JANX | USLM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.14% | -77.09% | -6.05% |
Max Drawdown (1Y)Largest decline over 1 year | -64.94% | -22.46% | -42.48% |
Max Drawdown (5Y)Largest decline over 5 years | — | -45.87% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.87% | — |
Current DrawdownCurrent decline from peak | -78.29% | -13.51% | -64.78% |
Average DrawdownAverage peak-to-trough decline | -51.08% | -27.37% | -23.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.01% | 8.31% | +30.70% |
Volatility
JANX vs. USLM - Volatility Comparison
Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM) have volatilities of 12.78% and 12.79%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JANX | USLM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.78% | 12.79% | -0.01% |
Volatility (6M)Calculated over the trailing 6-month period | 86.72% | 26.79% | +59.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.41% | 38.59% | +40.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 133.55% | 34.94% | +98.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 133.55% | 35.89% | +97.66% |
Financials
JANX vs. USLM - Financials Comparison
This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and United States Lime & Minerals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities